Chargement en cours...
A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group.
We describe a phase III trial on 200 patients with end stage squamous cell carcinoma of the head and neck. The patients were randomised to one of four treatment arms: cisplatinum alone, methotrexate alone, cisplatinum + 5-FU and cisplatinum + methotrexate. There was no significant difference in the...
Enregistré dans:
| Format: | Artigo |
|---|---|
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
1990
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1971415/ https://ncbi.nlm.nih.gov/pubmed/2178667 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|